Related Experiment Video
Updated: Jul 15, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Synthetic approaches to the 2005 new drugs
Subas M Sakya1, Jin Li, Kevin K-C Liu
1Pfizer Global Research and Development, Pfizer, Inc., Groton, CT 06340, USA. subas.m.sakya@pfizer.com
Abstract:
New drugs are introduced to the market every year and each individual drug represents a privileged structure for its biological target. In addition, these new chemical entities (NCEs) not only provide insights into molecular recognition, but also serve as drug-like leads for designing future new drugs. To these ends, this review covers the syntheses of 22 NCEs marketed in 2005.
Related Concept Videos
Drug Discovery: Overview
Synthetic Biology
Golden rice
Golden rice is a genetically modified...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Clinically Relevant Drug Product Specifications: Methods of Establishment
Drug Regulation
Pharmacogenomics: Identification of New Drug Targets

